PTCommunity News September 2016

More Positive Data Reported for Lupus Nephritis Treatment Voclosporin
Oral, First-in-Class Schizophrenia Drug Stumbles in Phase 3 Trial
HCV Regimen Receives Breakthrough Therapy Designation
Big-Name Hospitals Get Low Marks for Preventing C. difficile Infections
Need to Replace EpiPens Regularly Adds to Cost Concerns
Research Sheds Light on Mechanism That Leads to Drug-Resistant ‘Superbugs’
Migraine Drug Erenumab Succeeds in Phase 3 Trial
FDA Approves First Automated Insulin Delivery Device for Type-1 Diabetes
FDA Expands Orkambi Label to Include Cystic Fibrosis Patients Ages 6 Through 11
Congress Finally Approves Funding to Fight Zika Virus
CDC Teams Up With Dialysis Groups to Reduce Infections
FDA Accepts Application for Osteoporosis Drug Romosozumab
Researchers Discover How Resveratrol Reduces Airway Inflammation
FDA Approves Diabetes Sensing System
Expert Demoted After Questioning CDC’s Zika Test
Workplace Depression Across Eight Countries Said to Cost $246 Billion
Do Gut Microbiomes of Hispanics/Latinos Influence Their Diabetes Risk?
Kyprolis Combo Fails to Meet Endpoint in Phase 3 Multiple Myeloma Trial
Experts Recommend Continuous Glucose Monitors for Adults with Type-1 Diabetes
New Collaboration Will Evaluate Combination of Opdivo and NKTR-214
NIH Funds Research Network Focused on HIV-Infected Youth
FDA Expands Indications for Ilaris for Three Rare Diseases
Dupilumab Application Accepted for FDA Priority Review
Stelara Receives FDA Approval for the Treatment of Crohn's Disease
FDA Approves Amjevita, the First Humira Biosimilar
Anticipated Alzheimer’s Drug Fails in Late-Stage Study
Tattoo Therapy for Chronic Diseases
How Does Tecfidera Work?
Ceritinib (Zykadia) Succeeds in Lung Cancer Trial
Injection Drug Use Blamed for Rise in Heart Infections
Newron Pharma Resubmits Application for Parkinson’s Drug Safinamide (Xadago)
Bundled Payments May Have Unintended Consequences
UnitedHealth Trims Drug Coverage
Did Abbott Sales Reps Help Spur the Opioid Epidemic?
Report: Medicare EpiPen Spending Up 1,100%
Low-Dose Phentermine (Lomaira) Wins FDA Nod for Weight Loss
FDA Approves Invokamet XR for Treatment of Adults With Type-2 Diabetes
Report: Capping Copays Will Raise Premiums and Drug Prices
Survey: Most Physicians Downbeat About Future of Medicine
Approval of Muscular Dystrophy Drug Causes Uproar at FDA
FDA Places Clinical Hold on Leukemia Drug
Wearable Device Helps Reduce Hypoglycemia
FDA Approves Disposable Colonoscope
Kratom: Innocuous Pain Reliever or Dangerous Drug?
CDC Study: Hospitals Still Use Too Many Antibiotics
Cytomegalovirus Vaccine Flops in Mid-Stage Trial
Romosozumab Reduces Fractures in Postmenopausal Women With Osteoporosis
Contraceptive Device Kyleena Wins FDA Nod
FDA Grants Accelerated Approval to First Drug for Duchenne Muscular Dystrophy
Report: Antimicrobial Resistance May Wipe Out a Century of Health Care Progress
Simple Compound Could Provide First New Therapy for Myeloid Leukemia in 40 Years
Respiratory Virus Vaccine Flunks Phase 3 Study
Erenumab Shows Promise for Treatment of Chronic Migraine
World Should Prepare for Global Microcephaly ‘Epidemic,’ Authors Warn
Candidates Decry High Drug Prices, But Offer Few Options
Study: Shingles Vaccine Remains Effective After Four Years
Sublingual Sufentanil Found Safe in Late-Stage Trial
Yosprala Wins FDA Nod for Secondary Prevention of Cardio- and Cerebrovascular Events in Patients at Risk for Aspirin-Induced Gastric Ulcers
FDA Advisors Recommend Dropping Boxed Warning in Chantix Label
Bladder Cancer Drug Apaziquone (Qapzola) Not Effective, FDA Panel Says
Stem Cell Therapy Shows Promise in Spinal Cord Paralysis
FDA Approves Cuvitru for Treatment of Primary Immunodeficiencies
Common Breast Cancer Test May Not Be Worth the Cost
CDC: Poor Blood Pressure Control Puts Five Million Older Americans at Risk
Report: EpiPen Execs Are Second-Best Paid in the Industry
NMDA Receptor Modulator Wins Fast-Track Designation for Treatment of Diabetes-Related Neuropathic Pain
Snail Venom: The Key to Better Diabetes Treatments?
Idebenone (Raxone) Improves Inspiratory Function in Patients With Duchenne Muscular Dystrophy
FDA Report: Cancer Drug Websites Skimp on Safety Data
Study: Opioid-Related Health Spending Jumped More than 1,300% in Four Years
Aveo Quietly Terminates Ficlatuzumab Study
Scientists Identify Previously Undiscovered Role of Enzyme in Regulating Blood Pressure
FDA Approves Obalon Balloon System
FDA Panel Unimpressed by Varenicline (Chantix) Smoking-Cessation Study
Study: Discarding Unused Surgical Supplies Wastes Millions of Dollars
Oral Sotagliflozin Succeeds in Phase 3 Diabetes Trial
Study Could Herald New Treatment for Muscular Dystrophy
FDA to Skip Review Panel for Cancer Drug Candidate Rucaparib
Affordable Care Act Puts the Squeeze on EDs
Behind the EpiPen Monopoly: Lobbying Muscle, Faltering Competition
Company Prepares to Submit Cannabis-Based Epilepsy Treatment to FDA
Patients With Advanced Lymphoma in Remission After T-Cell Therapy
Blue Ribbon Panel Offers Recommendations for Improving Cancer Outcomes
Senate to Probe EpiPen Pricing
Reuters Report: U.S. Fails to Track Rising ‘Superbug’ Toll
Paralyzed Man Regains Use of Arms and Hands After Experimental Stem Cell Therapy
Lasmiditan Achieves Key Endpoints in Pivotal Migraine Study
Keytruda Wins Priority Review for First-Line Treatment of Advanced Lung Cancer
Study Ranks Best and Worst States for Health Care Costs, Access
Senate Fails to Pass Zika Funding Bill––Again
Saline Could Work as Well as Drugs for Preventing Nosebleeds
Home Noninvasive Ventilation Therapy Reduces Risk of Rehospitalization and Death in COPD
Tiotropium Respimat Improves Lung Function in Children With Asthma
Positive Phase 3 Results for Benralizumab in Severe Asthma
Survey Finds Gaps in Americans’ Knowledge About Zika
Study: Extreme Preemies Must Watch Blood Sugars and Weight
HHS Awards $19.8 Million to Japanese Company to Accelerate Development of a Zika Vaccine
FDA Issues Final Rule on Safety and Effectiveness of Antibacterial Soaps
FDA Approves Blinatumomab for Use in Pediatric Patients With Ph– Relapsed or Refractory B-Cell Precursor ALL
Merck Halts Odanacatib Development Program
Experimental P. aeruginosa Vaccine Bites the Dust
FDA Accepts Application for Melanoma Drug Binimetinib
Experimental Alzheimer’s Treatment Is Potential “Game Changer”
After FDA Rejection, New Data Offered on Factor Xa Inhibitor Antidote AndexXa
FDA Strengthens Warning on Opioid/Benzodiazepine Combinations

You are here

PTCommunity News September 2016